Owen
Egan
For Dr. Raymond Hakim, MDCM’76,
McGill has always been a family affair. His brother is a neurologist who worked
for many years at the Montreal Neurological Institute, and his sister earned a
Bachelor of Science from McGill in 1974. More recently, Dr. Hakim’s two nieces
attended McGill, both earning degrees from the Faculty of Science.
Dr. Hakim himself is now the
chief medical officer and senior executive vice-president of Fresenius Medical
Care North America, the largest integrated provider of products and services
for individuals with chronic kidney failure, a condition that affects more than
1.4 million individuals worldwide.
Yet despite living in
“The Catherine McLaughlin Hakim
Chair comes at a time when the Faculty of Medicine is experiencing
unprecedented growth and is garnering international attention for its many
achievements in teaching and research,” says the Faculty’s Dean, Dr. Richard
Levin.
The first holder of the chair is
Dr. Andrey V. Cybulsky,
Professor of Medicine and Director of the Nephrology Division, which provides
patient care, conducts research and oversees teaching in the diagnosis and
treatment of kidney disease.
“I sincerely thank Dr. Hakim and
his family for their generous support. The endowment they have created will
enhance the profile of the Nephrology Division and help us maintain and acquire
the expertise needed to fight chronic kidney disease and end-stage renal
failure,” says Dr. Cybulsky.
An estimated two million
Canadians have kidney disease or are at risk of developing the illness. Each
day, about 14 Canadians learn that their kidneys have failed — a condition that
can prove fatal if not treated immediately. The Catherine McLaughlin Hakim
chair will provide a major boost to Canadian research in this important field
and ensure that McGill leads the way.
Montreal
Copyright
© 2008
McGill University
Page
last updated:
Nov. 14, 2007 at 12:12 PM